sc 41661a has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alrefai, W; Anderson, KM; Harris, JE; Meng, J; Mulshine, J; Ou, D; Seed, T; Vos, M | 1 |
| Alrefai, WA; Anderson, KM; Harris, JE; Meng, J | 1 |
2 other study(ies) available for sc 41661a and Cancer of Prostate
| Article | Year |
|---|---|
5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death.
Topics: Amides; Cell Death; Cell Division; Cell Survival; Humans; Indoles; Lipoxygenase Inhibitors; Male; Microscopy, Electron; Polymerase Chain Reaction; Prostatic Neoplasms; Pyridines; RNA, Messenger; Tumor Cells, Cultured | 1998 |
Five-lipoxygenase inhibitors reduce Panc-1 survival: synergism of MK886 with gamma linolenic acid.
Topics: 5-Lipoxygenase-Activating Proteins; Amides; Apoptosis; Arachidonate 5-Lipoxygenase; Carrier Proteins; Cell Survival; Drug Synergism; gamma-Linolenic Acid; Humans; Indoles; Lipoxygenase Inhibitors; Male; Membrane Proteins; Pancreatic Neoplasms; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyridines; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; U937 Cells | 1999 |